Indian pharmaceutical major, Dr Reddy's Laboratories has reported a rise of 2.46 per cent in consolidated net profit to Rs 342.70 crore for the fourth quarter for the financial year till March 2012.

The company had recorded a net profit of Rs 334.47 crore during the same period of previous fiscal year, according to a fling by the company with the Bombay Stock Exchange (BSE). The net income of the company increased to Rs 2,658.45 crore during quarter compared to Rs 2,017.27 crore in the same quarter of the previous fiscal year. The company's net sales rose 32 per cent to Rs 2,658.5 crore during the fourth quarter.

As for the whole financial year, the company recorded a net profit of Rs 1,426.21 crore compared to Rs 1,104 crore in 2010-11 fiscal. Its net income from sales and service for the whole year was at Rs 9,673.74 crore, compared to Rs 7,469.28 crore in the previous fiscal.

The company might offer a dividend of Rs 13.75, which is about 275 per cent of the equity share of Rs 5 each.